Online Inquiry
TNFRSF8/CD30 Antibody
SPA-10995
Size | Price |
100 µg | Online Inquiry |
25 µg | Online Inquiry |
More Options | Online Inquiry |
Target Information | |
---|---|
Target Name | TNF receptor |
Gene Abbr. | TNFRSF8 |
Gene ID | 943 |
Full Name | TNF receptor superfamily member 8 |
Alias | CD30, D1S166E, Ki-1 |
Introduction | TNFRSF8/CD30 is a type-I transmembrane glycoprotein that is a member of the TNFR superfamily. CD30 is synthesized as a precursor protein that undergoes extensive posttranslational modification before becoming embedded in the plasma membrane as a 120-kDa transmembrane protein. The expression of CD30 is upregulated in activated T-cells and may trigger costimulatory signaling pathways upon its engagement. While its expression is normally restricted to subsets of activated T-cells and B-cells, CD30 expression is robustly upregulated in hematologic malignancies, such as Hodgkin’s lymphoma anaplastic large cell lymphoma (ALCL), and adult T-cell leukemia, thus making it an attractive target for therapeutic intervention. Research studies have suggested that in certain disease contexts, CD30 recruits TRAF2 and TRAF5 adaptor proteins to drive NF-kappa B activation, aberrant cell growth, and cytokine production. CD30 signaling is also regulated by TACE-dependent proteolytic cleavage of its ectodomain, which results in reduced CD30L-dependent activation of CD30+ cells. |
Product Details | |
---|---|
Host | Goat |
Clonality | Polyclonal |
Clone No. | N/A |
Isotype | IgG |
Immunogen | Mouse myeloma cell line NS0-derived recombinant mouse CD30/TNFRSF8. Phe19-Thr281. Accession # Q60846. |
Usage | |
---|---|
Application | WB, IF |
Dilutions | Western Blot (0.1 µg/mL); Immunofluorescence (5-15 µg/mL) |
MW(KDa) | 90 (precursor), 120 (mature) |
Reactivity | Mouse |
Specificity | Detects CD30/TNFRSF8 in direct ELISAs and Western Blots. |
Storage & Handling | |
---|---|
Storage Buffer | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. |
Preservative | No Preservative |
Storage Temp. | 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution. |
Handling | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.